-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis: Poster III

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Xue Chen, MD1*, Lili Yuan, MD1*, Fang Wang, MD2*, Yang Zhang, MD2*, Xiaoli Ma, MD2*, Panxiang Cao, MD1*, Jiancheng Fang, MD3*, Tong Wang, MD1*, Jiaqi Chen, PhD4*, Xiaosu Zhou, PhD5* and Hongxing Liu, MD1,6

1Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Department of Clinical Laboratory, Hebei Yanda Lu Daopei Hospital, Langfang, China
3Department of Clinical Laboratory, Hebei Yanda Lu Daopei Hospital, Langfang, Hebei, China
4Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, China
5Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, AL, China
6Precision Medicine Center, Beijing Lu Daopei Institute of Hematology, Beijing, China

Nadine Wolgast1,2,3*, Thomas Beder1,2,3*, Mayukh Mondal2,4*, Wencke Walter, PhD5, Stephan Hutter, PhD5*, Sonja Bendig1,2,3*, Jan Kässens1,3*, Björn-Thore Hansen3,6,7*, Katharina Iben1,2,3*, Barz Malwine1,2,3*, Martin Neumann, MD1,2,3*, Nicola Goekbuget, MD8, Claudia Haferlach, MD5, Monika Brüggemann, MD1,2,3*, Claudia D Baldus, MD1,2,3*, Alina M. Hartmann2,3,9* and Lorenz Bastian1,2,3*

1Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
2Clinical Research Unit CATCH ALL (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Kiel, Germany
3University Medical Center Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany
4Christian Albrechts University Kiel, Institute for Clinical Molecular Biology, Kiel, Germany
5MLL Munich Leukemia Laboratory, Munich, Germany
6(DFG, German Research Foundation): 413490537, Clinician Scientist Program in Evolutionary Medicine funded by the Deutsche Forschungsgemeinschaft, Kiel, Germany
7Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
8Hematology/Oncology, Goethe University Hospital, Frankfurt/M., Department of Medicine II, Frankfurt/M., Germany
9Department of Internal Medicine II (Hematology/Oncology), University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany

Mingying Zhang1*, Yuanyuan Zhang1*, Peijing Qi1*, Wei Lin1*, Ying Wu1*, Jiaole Yu1*, Huyong Zheng2 and Ruidong Zhang1*

1Hematology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
2Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Hematology Center, Beijing, China

Hrishi Venkatesh, PhD1*, Kyra Boorsma Bergerud1*, Miriam A. Arroyo2*, Enoc Granadas Centeno2*, Todd P. Knutson3*, Yinjie Qiu, PhD3*, Kristina Springer4*, Xenia Meshik, PhD4*, Veronika Bachanova, MD, PhD5, Michael A. Farrar, PhD6 and Sean I. Tracy, MD, PhD7*

1Center for Immunology, University of Minnesota, Minneapolis, MN
2420 Delaware St. SE., MMC 480, University of Minnesota, Minneapolis, MN
3Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN
4Bruker Spatial Biology, Saint Louis, MO
5Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
6Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
7Center for Immunology, Masonic Cancer Center, Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Venkata Sesha Sai Abhinav Ayyadevara, PhD, MS1*, Ashley Paik2*, Ria Perencsik3*, Monika Toma, PhD4*, Tomasz Skorski, MD, PhD4, Rozbeh Jafari, PhD5*, Gerald Wertheim, MD, PhD6*, Huimin Geng, PhD7* and Christian Hurtz, PhD8

1Division of Cancer Sciences, Loma Linda University, Philadelphia, PA
2Southern Adventist University, Collegedale, TN
3University of British Columbia, Vancouver, Canada
4Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine, Philadelphia, PA
5Department of Oncology-Pathology and Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden
6Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
7Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
8Division of Cancer Sciences, Loma Linda University, Loma Linda, CA

Giacomo Gotti, MD1*, Claudia Saitta2*, Daniela Silvestri2*, Arianna Colombo2*, Federica Colnaghi2*, Stefano Rebellato2*, Matilde Marzorati2*, Nicolò Peccatori2*, Nicoletta Bertorello, MD3*, Luca Lo Nigro, MD4, Franco Locatelli, MD5, Rosanna Parasole6*, Maria Caterina Putti7*, Valentino Conter, MD2*, Antonella Colombini, MD1*, Barbara Buldini, MD, PhD8, Andrea Biondi1,9, Maria Grazia Valsecchi, PhD9,10*, Giovanni Cazzaniga, PhD2,9, Grazia Fazio, PhD2,9* and Carmelo Rizzari, MD, PhD1*

1Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
2Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
3Pediatric Oncohematology, University of Turin-Regina Margherita Children Hospital, Turin, Italy
4Center of Pediatric Hematology Oncology, Azienda Policlinico “San Marco", Catania, Italy
5IRCCS Bambino Gesù Children's Hospital, Rome, Italy
66 Department of Pediatric Oncology, Hematology and Cellular Therapy, AORN Santobono-Pausilipon, Naples, Italy
7Department of Pediatric Hematology and Oncology, University of Padova, Padova, Italy
8University of Padova, Padua, Italy
9School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
10Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy

Lukasz Sedek, Ph.D.1*, Beatriz Soriano2*, Łukasz Słota3*, Monika Brüggemann4*, Aleksandra Lasia3*, Saskia Kohlscheen4*, Michaela Reiterova5*, Stefan Nierkens, PhD6*, Anja De Jong6*, Giuseppe Gaipa7, Cristina Bugarin, MSc7*, Cristiane Ferreira-Facio8*, Elaine Sobral da Costa8*, Ludovic Lhermitte9*, Julia Almeida2*, Alberto Orfao, MD, PhD2*, Jacques JM van Dongen, MD, PhD2,10* and Tomasz Szczepanski, MD, PhD3

1Department of Microbiology and Immunology, Medical University of Silesia, Zabrze, Poland
2Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain
3Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland
4University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
5CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
6Princess Maxima Center, Utrecht, Netherlands
7Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
8University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
9Laboratory of Onco-Hematology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
10European Scientific Foundation for Laboratory Hemato-Oncology (ESLHO), Zutphen, Netherlands

Sogand Sajedi, PhD, Nicholas J. Short, MD, Enes Dasdemir, BS*, Bofei Wang, PhD, Cedric Nasnas, MD*, Elias Jabbour*, Hagop M. Kantarjian, MD, Patrick K. Reville, MD, MPH and Hussein A. Abbas, MD, PhD

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

So Yeon Park1,2*, Jae-Ho Yoon, MD, PhD1,2, Daehun Kwag1,2*, Jung Yeon Lee1,2*, Gi June Min, MD, PhD1,2, Sung-Soo Park, MD, PhD1,2*, Silvia Park, MD, PhD1,2*, Sung-Eun Lee, MD, PhD1,2*, Byoung-Sik Cho, MD, PhD1,2*, Ki-Seong Eom, MD, PhD1,2*, Yoo-Jin Kim1,2, Hee-Je Kim, MD, PhD1,2, Chang-Ki Min1,2*, Seok-Goo Cho1* and Seok Lee, MD1,2

1Department of Hematology, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Meera Patel, MD1*, Ahmed N Mohamed, MD2*, Hadil Zureigat, MD2, Emily C. Zabor, DrPH3*, Daniel P. Nurse, DO2*, Yohana B. Bedelu3*, Mark Jinan Chen, PhD4*, Joy Nakitandwe, PhD5*, Akriti G. Jain, MD6, John C. Molina, MD, MEd6, Sophia Balderman, MD6*, Abhay Singh, MD, MPH6, Aaron T. Gerds, MD, MS6, Sudipto Mukherjee, MD, PhD, MPH6, Hetty E. Carraway, MD, MBA6, Anjali S. Advani, MD6 and Moaath K. Mustafa Ali, MD, MPH6

1Department of Internal Medicine, Cleveland Clinic, Elgin, IL
2Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
3Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Diagnostics Institute, Cleveland Clinic Department of Pathology and Laboratory Medicine, Cleveland, OH
5Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Alexander Chassiakos, BSc*, Ming Zhan, MD/PhD*, Zhilian Jia, PhD*, Zunsong Hu, PhD and Zhaohui Gu, PhD

City of Hope, Duarte, CA

Burak Yuzuguldu, MD1*, Caroline R.M. Wiggers, PhD2*, Nathaniel G. Tadros2*, Eugene Y. Cho2*, Jens G. Lohr, MD, PhD3 and Birgit Knoechel, MD, PhD2

1Pediatric Oncology, Dana Farber Cancer Institute, BUFFALO, NY
2Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA
3Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Iman Sarami, MD1*, Ruchi Singhal, MD1*, Mark Routbort, MD, PhD2*, Koji Sasaki, MD3, Daniel Domogala III4*, Gokce A. Toruner, MD PhD5*, Shibu Ninan6*, Nitin Jain, MD3, Keyur P. Patel, MBBS, PhD7, Elias Jabbour, MD8, Hagop M. Kantarjian, MD3, Carlos E. Bueso-Ramos, MD, PhD7, L. Jeffrey Medeiros, MD7, Raja Luthra, Ph.D2*, Guilin Tang, MD, PhD7* and Rashmi Kanagal-Shamanna, MD9

1The University of Texas MD Anderson Cancer Center, Houston, TX
2Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University fo Texas MD Anderson Cancer Center, Houston
5Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston
7Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
9Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Yu Xia1,2*, Kai Wang1*, Keyan Yang3*, Ling Jin4*, Ying Liu, MD5*, Yueping Jia6*, Yunpeng Dai7*, Lihua Yang8*, Rong Liu9*, Lian Jiang10*, Zhongjin Xu11*, Ansheng Liu12*, Xiaojun Yuan13*, Jian Wang14*, Yonghong Zhang, MD5* and Qinlong Zheng, MD2*

1Beijing Gobroad Boren Hospital, Beijing, China
2Laboratory of Molecular Diagnostics, Beijing GoBroad Boren Hospital, Beijing, China
3Department of Medical Laboratory, Beijing Gaobo Boren Hospital, Beijing, China
4Department of Hematology/Oncology, National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University, Beijing, China
5Department of Pediatric Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China
6Department of Pediatrics, Peking University People's Hospital, Beijing, China
7Department of Pediatrics Hematology and Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
8Department of Pediatric Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
9Capital institute of pediatrics affiliated children's hospital, Beijing, Beijing, China
10Department of Pediatrics, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
11Jiangxi Provincial Children's Hospital, Nanchang, China
12Xi'an Children's Hospital, Xi'an, China
13Department of Pediatric Hematology/Oncology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
14Department of Hematology and Oncology, Anhui Provincial Children’s Hospital, Hefei, China

Jansen N Seheult, M.D.1*, Matthew J Weybright1*, Min Shi, MD, PhD2*, Dragan Jevremovic, M.D., Ph.D3*, April Chiu, MD1*, Michael M Timm1*, Gregory E Otteson1*, Horatiu Olteanu, M.D., Ph.D.1 and Pedro Horna, MD1

1Division of Hematopathology, Mayo Clinic, Rochester, MN
2Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, MN
3Mayo Clinic, Rochester, MN

Sandro S Bräunig, PhD1*, Carl Dencker, MS1*, Dang Nghiem Vo, PhD1*, Anne Hultquist, MD, PhD1,2*, Jens Enoksson, MD, PhD2*, Hongzhe Li, PhD1* and Stefan Scheding, MD1,3

1Division of Molecular Hematology and Stem Cell Center, Lund University, Lund, Sweden
2Laboratory Medicine Skane, Department of Clinical Pathology, Lund, Sweden
3Hematology, Skane University Hospital, Lund, Sweden

Babette D. J. Hoen*, Tamara J. J. Manuputty*, Judith M. Boer, PhD, Cesca Van De Ven, PhD* and Monique L. den Boer, PhD

Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

Caleb Ho, MD1, Natalie Danziger2*, Jessica Lee2*, Douglas Lin, MD2*, Richard Huang, MD3*, Chelsea Marcus, MD2* and Douglas Mata, MD, MPH4*

1Pathology, Foundation Medicine, Cambridge, MA
2Pathology, Foundation Medicine, Boston, MA
3Clinical Development, Foundation Medicine, Boston, MA
4Molecular Pathology, Foundation Medicine, Cambridge, MA

*signifies non-member of ASH